CFTR and cystic fibrosis: CFTR, the Cl−/bicarbonate channel affected in cystic fibrosis, contributed to the baseline short-circuit current in our preparation as evidenced by a drop in ISC upon administration of its inhibitor CFTRinh172 (25 μM) but did not convey the succinate effect which remained unaffected by CFTR blockade (fig.